Contera Pharma A/S is a Danish A/S based in Hørsholm, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2010, the company has 20 employees and reported revenue of 20,6 mio. kr. in its latest annual filing.
20,6 mio. kr.
−138% vs 2024
-4,8 mio. kr.
+93% vs 2024
Solidity ratio Equity ÷ Total assets × 100 2021 2025
Liquidity ratio Current assets ÷ Short-term debt 2021 2025
Return on assets (ROA) Net profit ÷ Total assets × 100 2021 2025
EBITDA — year on year DKK millions 0M -24M -48M -72M -96M 2021: -36M -36M 2021 2022: -58M (-61% vs 2021) -58M -61% 2022 2023: -77M (-33% vs 2022) -77M -33% 2023 2024: -74M (+4% vs 2023) -74M +4% 2024 2025: -4M (+95% vs 2024) -4M +95% 2025
Key figures Annual report 2025 Revenue 20,6 mio. kr. -138% EBITDA -4,2 mio. kr. +94% Net profit -4,8 mio. kr. +93% Total assets 97,6 mio. kr. +53% Equity 79,5 mio. kr. +46% Employees 20 —
Legal name
CONTERA PHARMA A/S
Founded
9 July 2010 · 16 years
Share capital
DKK 4.198.724
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsesformanden i forening med selskabets administrerende direktør.
Company purpose
Selskabets formål er at udvikle nye lægemidler og dermed beslægtet virksomhed.
(no translation available)
Email
ts@conterapharma.com
Website
www.conterapharma.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Explore Financial development In its most recent annual report (2025), Contera Pharma A/S reported a gross profit of 20,6 mio. kr.. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of 4,8 mio. kr., and the EBITDA margin stood at -20.2%.
At the end of 2025, equity financed 81.5% of the balance sheet, and current assets covered short-term debt 5 times. Contera Pharma A/S is one of 2 companies registered under Research and experimental development on natural sciences and engineering in Denmark.
Frequently asked questions What is the CVR number of Contera Pharma A/S? Contera Pharma A/S is registered with CVR / Virk under CVR 33062214.
What is the revenue of Contera Pharma A/S? Contera Pharma A/S reported revenue of 20,6 mio. kr. in 2025.
How many employees does Contera Pharma A/S have? Contera Pharma A/S employs 20 people as of the latest annual report.
Who is the CEO of Contera Pharma A/S? Thomas Nikolaj Sager is the CEO of Contera Pharma A/S, in role since 2020.
Who is the chairman of Contera Pharma A/S? Mi Chung Ahn chairs the board of Contera Pharma A/S, in role since 2026.
Where is Contera Pharma A/S headquartered? Contera Pharma A/S's registered address is Venlighedsvej 4.
More on Contera Pharma A/S 